| Document |
Document Title |
|
WO/2022/131654A1 |
The present invention relates to a water-soluble emulsion composition containing ecdysteroid containing a water-soluble antioxidant emulsion. The water-soluble emulsion composition containing ecdysteroid according to one implemented embo...
|
|
WO/2022/127050A1 |
A compound of formula I or a pharmaceutically acceptable salt, isomer, prodrug, polymorph or solvate thereof, a preparation method therefor, a pharmaceutical use thereof and a pharmaceutical composition comprising same. The compound has ...
|
|
WO/2022/122730A1 |
Compositions may be used for a variety of therapeutic applications, including treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, in particular in condition of oxidative stress, such ...
|
|
WO/2022/116356A1 |
The present invention provides marine polysaccharide vector-based anthocyanin nanoparticles. A marine polysaccharide, foodborne fluorescent nanoparticles, and sodium hyaluronate are used as a composite vector to be combined with anthocya...
|
|
WO/2022/118186A1 |
It is provided a senotherapeutic compound comprising a synthetic derivative of flavones, according to the formula (I), in which at least two of R2-R6 are H, and the remainder are individually selected from: H, OH, R1, OR1, NO2, NH2, NHR1...
|
|
WO/2022/116981A1 |
An application of a polyanionic cellobioside compound, particularly, an application of a compound as represented by formula II in preparation of a medication for treatment of a related disease or disorder caused by 2019-nCoV infection. T...
|
|
WO/2022/118183A1 |
It is provided a senotherapeutic substance characterized by comprising flavonoids, fatty acids, and, preferably, phenolic acids and / or vitamins.
|
|
WO/2022/110090A1 |
Disclosed in the present invention is an anti-ageing health-care product, wherein the anti-ageing health-care product comprises Cordyceps sinensis, broccoli seeds, a carrot extract, Gynostemma pentaphyllum, a grapeseed extract, lycopene,...
|
|
WO/2022/105726A1 |
A production method for lycopene-containing granules with an efficient antioxidation effect. The method comprises: extracting Ganoderma lucidum spore oil from Ganoderma lucidum spore powder having a broken sporoderm rate of 90%-92% by me...
|
|
WO/2022/105877A1 |
Disclosed are a pharmaceutical composition comprising a bilobalide component and a pharmaceutically acceptable carrier or excipient, and a pharmaceutical preparation of a bilobalide component comprising a bilobalide component, a pharmace...
|
|
WO/2022/108479A1 |
The invention relates to a composition based on a natural lignocellulose complex, a source of dietary fiber exhibiting antioxidant and adsorption properties and dihydromyrecitin or quercetin, which has hepatoprotective activity when used...
|
|
WO/2022/105770A1 |
Disclosed is an anti-aging regeneration composition, wherein the raw materials are a tea component and sodium chloride, wherein the tea component comprises one or more of a vitamin, amino acid, alkaloid, tea polyphenol, fatty acid ester,...
|
|
WO/2022/102869A1 |
The present invention relates to a cosmetic composition, a pharmaceutical composition or a food composition for antioxidation, whitening, anti-wrinkle or anti-inflammation containing egg yolk oil and Agastache rugose stem cells as active...
|
|
WO/2022/102737A1 |
Provided is a pharmaceutical composition having edaravone as an active ingredient for oral administration or administration equivalent thereto. The pharmaceutical composition of the present invention contains edaravone as an active ing...
|
|
WO/2022/102652A1 |
The present invention provides a novel compound, which has a TLR4 activating effect and is usable as an immune activator or adjuvant in vaccine or allergen immunotherapy, or a pharmaceutically acceptable salt thereof. A compound repres...
|
|
WO/2022/099574A1 |
An application of prazosin in preparation of drugs for treating and/or preventing cerebrovascular diseases, especially an application in preparation of drugs for treating cerebral ischemic stroke. The main mechanisms against ischemia eva...
|
|
WO/2022/100567A1 |
The present application provides a use of a hyaluronic acid or a salt thereof and/or trehalose in stabilizing ergothioneine, an additive for stabilizing ergothioneine, the additive containing the hyaluronic acid or the salt thereof and/o...
|
|
WO/2022/098014A1 |
The present invention relates to a composition for preventing or treating progeria through gene editing, the composition containing sgRNA to be hybridized with mRNA, which encodes progeria-causing progerin, and a gene encoding a Cas13 pr...
|
|
WO/2022/092687A1 |
The present invention relates to a composition comprising a protein expression inhibitor for antioxidation, antiinflammation, and dementia prevention or alleviation, and a use thereof. The composition can suppress neural cell death induc...
|
|
WO/2022/089591A1 |
The application of glucosamine in the preparation of drugs for the treatment of non-alcoholic fatty liver disease and diabetes. Experiments have proven that glucosamine at a daily dose of 300-600 mg/kg can improve insulin resistance, gly...
|
|
WO/2022/083437A1 |
A water-soluble astaxanthin nanoemulsion and a preparation method therefor. An astaxanthin diaphragm sheet prepared from the astaxanthin nanoemulsion and a preparation method therefor. A heating-type anti-fatigue eye care package and eye...
|
|
WO/2022/083632A1 |
An application of a Sesquiterpene lactone compound, and a stereoisomer, isotopic marker, solvate and polymorph thereof, or a pharmaceutically acceptable salt thereof in the preparation of drugs for alleviating radiotherapy-induced injuri...
|
|
WO/2021/113938A9 |
The food supplement is intended to reduce the side effects and toxicity related to chemotherapy in patients with breast cancer, prostate cancer, colon cancer and lung cancer and includes the following active substances: tryptophan [(R)-2...
|
|
WO/2022/075444A1 |
A problem addressed by the present invention is to provide a low-molecular compound that has relatively high safety when ingested, that can be ingested orally, that can be produced relatively inexpensively, and that has anti-ferroptosis ...
|
|
WO/2022/075185A1 |
In one aspect, a method for producing an extract composition is provided, whereby it becomes possible to extract an essential oil component such as a polyphenol, e.g., apigenin apigenin, and/or a spiro ether with high efficiency from a h...
|
|
WO/2022/073438A1 |
Disclosed in the present invention are a nanoparticle with high loading of phycocyanin, and a preparation method therefor and the use thereof. According to the present invention, a phycocyanin solution, a PAMMA solution, a tannic acid so...
|
|
WO/2022/071771A1 |
The subject to be achieved by the present invention is to provide a more effective, novel protein transduction domain and a fusion compound. In order to achieve the subject, the present inventors had selected and tested many candidate pe...
|
|
WO/2022/068615A1 |
A formulation for improving the activity and/or thermostability of superoxide dismutases and use thereof. The formulation comprises at least one of the following components: vitamin C, vitamin p, catechin, quercetin, myricetin, kaempfero...
|
|
WO/2022/071580A1 |
In the present invention, a low-molecular-weight compound 2,2,6,6-tetramtethyl-1-piperidinyloxyl (TEMPO) in the gas state is allowed to act on cells to suppress cell death associated with oxidative stress, thereby protecting tissue from ...
|
|
WO/2022/067774A1 |
A preparation method of a sea cucumber polysaccharide, comprising the following steps: (1) taking dry sea cucumbers, pulverizing the dry sea cucumbers into coarse particles, adding water to conduct enzymatic hydrolysis, performing centri...
|
|
WO/2022/068784A1 |
Provided are a selenium-rich Cordyceps militaris derived active selenium peptide with a neuron protection function, and a preparation method therefor and the use thereof. The amino acid sequence of the selenium-rich Cordyceps militaris d...
|
|
WO/2022/068629A1 |
A production method for accurately controlling the molecular weight and esterification degree of small molecular pectin by an enzyme-alkali combination method. The method comprises: first cracking the molecular weight of pectin to a targ...
|
|
WO/2022/068248A1 |
Provided is the use of a substance for reducing the content or activity of KAT7 in preventing aging and treating hepatic fibrosis. A knocked-down KAT7 gene has a definite effect in delaying aging and treating hepatic fibrosis diseases; a...
|
|
WO/2022/062380A1 |
The present invention discloses a Tibetan Ganoderma lucidum polysaccharide GLP-1 with an antioxidant effect, a preparation method and the use. The Ganoderma lucidum polysaccharide GLP-1 is extracted from Tibetan Ganoderma lucidum powder,...
|
|
WO/2022/062716A1 |
A composition having the function of nourishing yin and tonifying the kidney, and a preparation method therefor and the use thereof. The composition comprises, by weight, 1-10 parts of Poria, 1-5 parts of Polygonati rhizoma, 1-5 parts of...
|
|
WO/2022/062301A1 |
Use of magnesium hydride in the preparation of a composition for preventing and treating chronic periodontitis and a magnesium hydride toothpaste. The weight percentage content of magnesium hydride in said composition or magnesium hydrid...
|
|
WO/2022/061978A1 |
A compound composition with anti-oxidation and anti-aging effects, formed by mixing a traditional Chinese medicine extract and chitosan oligosaccharide in a weight ratio of (3-8):1. The traditional Chinese medicine extract is formed by i...
|
|
WO/2022/058422A1 |
The present invention relates to systemic detoxification and chronic inflammation by using methanolic extracts of Andrographis paniculata, that lead to a decrease of anti-inflammatory markers in human lung cell lines, which decreases the...
|
|
WO/2022/057498A1 |
A composition with the function of relieving physical fatigue and a preparation method therefor. The composition comprises the following components in parts by weight: 1-27 parts of Acanthopanacis senticosi radix et rhizoma seu caulis, 1...
|
|
WO/2022/057928A1 |
Provided is the carbonyl heterocyclic compound shown in formula (I) or a pharmaceutically acceptable salt thereof, capable of being used as a compound having a targeted lanthionine synthetase C-like protein 2 pathway and being used for t...
|
|
WO/2022/058965A1 |
Provided herein, inter alia, are compounds of fatty acid glycerol derivatives and compositions including the same.
|
|
WO/2022/053641A1 |
The present invention relates to a compound of formulas (II) to (V). It also relates to a pharmaceutical composition comprising at least one compound of formulas (II) to (V) and at least one pharmaceutically acceptable support. Finally, ...
|
|
WO/2022/053628A1 |
The present invention relates to a compound of formula (I). It also relates to a pharmaceutical composition comprising at least one compound of formula (I) and at least one pharmaceutically acceptable support. Finally, it relates to the ...
|
|
WO/2022/047779A1 |
Provided is the use of a nicotinamide mononucleotide in the preparation of a reagent for improving the level of a Na +-K +-ATP enzyme in sarcolemma of injured skin. According to the experiment regarding a UVB-induced mouse skin injury mo...
|
|
WO/2022/050492A1 |
The present invention relates to a functional composition for animals and use thereof and, more particularly, to: a functional composition for animals, comprising, as an active ingredient, a low-molecular ginsenoside isolated from proces...
|
|
WO/2022/047840A1 |
The present application pertains to the technical field of animal husbandry and veterinary medicine, and discloses a compound amino acid solution for an animal, a preparation method therefor, and an application thereof. The compound amin...
|
|
WO/2022/042428A1 |
A composition of ginsenoside Rg3 and ginsenoside Rg5, a preparation method therefor, and applications thereof in preparation of medications capable of improving drug resistance of immune, anti-tumor, and anti-tumor targeted medications, ...
|
|
WO/2022/045281A1 |
The purpose of the present invention is to provide a medicine that is for use in instances of cyanide poisoning, hydrogen sulfide poisoning, and azide poisoning, that does not cause side effects, and that has excellent quick-acting prope...
|
|
WO/2022/045418A1 |
The present invention relates to a health functional food for pain relief or antioxidation and a pharmaceutical composition for treatment of related diseases, each comprising a Siberian chrysanthemum extract. The extract can reduce react...
|
|
WO/2022/044014A1 |
Methods, compositions and kits for reducing renal tissue toxicity in a subject caused by a kidney damaging agent are provided. The methods comprise administering to the subject: (i) a kidney damaging agent; (ii) a PPARA activator; and (i...
|
